UBS Rates Constellation Brands (STZ) buy, $175 Price Target

UBS analyst Peter Grom maintains a 'buy' rating with a $175 target on Constellation Brands, a 22.73% upside from the current price.

By EarningsIQ Research Desk · Published Jun 17, 2026, 4:01 PM EDT · Updated Jun 24, 2026, 9:01 AM EDT

Reviewed by automated data checks against the source data. How we make and check alerts

UBS rated Constellation Brands, Inc. ($STZ) "buy" with a $175 price target on June 17, 2026.

Since the rating, $STZ is up 2.9% after 1 week, down 4.4% after 1 month and down 4.7% to date (from the $137.87 close on Jun 17, 2026).

STZ Constellation Brands, Inc.

$131.35 -4.98% year to date

Daily close · Oct 16, 2026

Key Points

UBS analyst Peter Grom reiterated a 'buy' rating on Constellation Brands, setting a price target of $175 on June 17, 2026.
UBS's $175 price target implies 22.73% upside from Constellation Brands, Inc.'s ($STZ) current $142.59 share price.
Constellation Brands (NYSE:STZ) trades at $142.15, with a market cap of $24.71 billion, a P/E ratio of 15.0, and a beta of 0.384.
Insider transactions include James Bourdeau's sale of 4,407 shares on May 12, 2026, at $143.24 each.

Get $STZ trade alerts by text

We text you when insiders, Congress or big funds trade $STZ. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Constellation Brands, Inc. alert may contain errors. Disclosures

UBS analyst Peter Grom has reiterated a 'buy' rating for Constellation Brands, Inc. (NYSE:STZ), setting a price target of $175. This reaffirmation on June 17, 2026, suggests confidence in the company's future performance.

Constellation Brands, Inc. Stock Up 19.9%

Shares of NYSE:STZ recently traded around $142.15. Constellation Brands boasts a market cap of approximately $24.71 billion. The company has a P/E ratio of 15.0 and a forward P/E of 11.6, indicating potential future earnings growth. It has a beta of 0.384, suggesting lower volatility compared to the market. The stock's 52-week range is between $126.45 and $178.14, with moving averages of $149.63 over 50 days and $146.10 over 200 days.

12-month forecast

$STZ price target

Constellation Brands, Inc. daily closes and this analyst's $175 target. Not advice.

Recent Earnings

In its latest earnings report, Constellation Brands posted revenue of about $9.14 billion, although it experienced a revenue decline of 11.3%. The company's net margin stands at 18.5%, and it has a return on equity of 22.6%. The next earnings release is scheduled for June 30, 2026.

Dividend

Constellation Brands offers an annual dividend rate of $4.12, yielding 2.86%. The dividend payout ratio is 42.46%, indicating a balanced approach to returning profits to shareholders.

Insider Buying and Selling at Constellation Brands, Inc.

Recent insider activity includes James Bourdeau, EVP and Senior Advisor, selling 4,407 shares on May 12, 2026, at an average price of $143.24. Additionally, Bourdeau bought 5,973 shares on May 1, 2026. EVP, CLO, & Secretary Jeffrey LaBarge sold 507 shares on May 1, 2026, at $152.82.

Analysts Set New Price Targets

On June 17, 2026, UBS maintained its 'buy' rating with a $175 price target. Other analysts have differing views; for instance, B of A Securities reiterated a 'sell' rating with a $152 target on May 28, 2026. The consensus among analysts is a 'buy' recommendation, with a mean price target of $176.09 based on 22 analyst opinions.

About Constellation Brands

Constellation Brands, Inc. is a leading beverage company headquartered in Rochester, New York. It produces and markets beer, wine, and spirits across several countries including the United States, Canada, and Mexico. The company's well-known beer brands include Corona and Modelo, while its wine portfolio features names like Robert Mondavi and Kim Crawford. CEO Nicholas Ian Fink leads the company, which employs around 9,400 people.

Bottom Line

UBS's reiteration of a 'buy' rating for Constellation Brands reflects continued confidence in the company's prospects. Investors often track such analyst updates, though it's important to remember that 13F filings and rating changes provide a snapshot of past positions and opinions, not current ones.